TapewireFind a company

person · Reporting owner

IMASOGIE OSAGIE O

Disclosed activity across 7 companies

Tapewire entity
85630
SEC CIK
0001275878

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
FS Investment Corp IIINONE · Entity 16526DirectorJuly 08, 2019July 15, 2019
FS Investment Corp IVNONE · Entity 152998DirectorJuly 08, 2019July 15, 2019
FS KKR Capital CorpFSK · Entity 776DirectorNovember 25, 2024November 26, 2024
FS KKR Capital Corp. IINONE · Entity 138043DirectorJuly 08, 2019July 15, 2019
IBERE PHARMACEUTICALSIBER · Entity 141979Director · Chief Executive Officer · 10% ownerFebruary 25, 2021February 25, 2021
KKR FS Income TrustNONE · Entity 15311DirectorMay 29, 2023May 30, 2023
KKR FS Income Trust SelectNONE · Entity 15233DirectorJune 07, 2023June 07, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

FS Investment Corp III

Report date July 08, 2019 · Filed July 15, 2019

This filing explicitly reported no securities owned.

FS Investment Corp IV

Report date July 08, 2019 · Filed July 15, 2019

This filing explicitly reported no securities owned.

FS KKR Capital Corp

Report date November 25, 2024 · Filed November 26, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect7,603 Reported balance After 2024-11-25 transaction · row 1
1 source row

Row 1 · 2024-11-25 · Sale · Disposed 40,885 · Balance 7,603

F1: The sales were effectuated in multiple transactions at prices ranging from $21.97 to $22.04. The price reported in Column 4 is the weighted average price

Filing footnotes · ownership attribution and instrument terms

F1: The sales were effectuated in multiple transactions at prices ranging from $21.97 to $22.04. The price reported in Column 4 is the weighted average price

FS KKR Capital Corp. II

Report date July 08, 2019 · Filed July 15, 2019

This filing explicitly reported no securities owned.

IBERE PHARMACEUTICALS

Report date February 25, 2021 · Filed February 25, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class B Ordinary SharesSEC Table II · derivative / convertible securityIndirectSee FootnoteNot disclosed Reported balance Holding disclosure · report date 2021-02-25 · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · Balance Not disclosed

F1: As described in the issuer's registration statement on Form S-1 (File No. 333-252863) (the "Registration Statement") under the heading "Description of Securities--Founder Shares," the shares of Class B ordinary shares, par value $0.0001 per share, will automatically be converted into shares of Class A ordinary shares, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis subject to adjustment pursuant to certain anti-dilution rights described therein.

F2: These shares represent Class B ordinary shares held by PIPV Capital LLC (the "Sponsor") acquired pursuant to a subscription agreement by and between the Sponsor and the issuer and a subsequent share dividend of Class B ordinary shares to the Sponsor. The Class B ordinary shares owned by the Sponsor includes up to 450,000 shares that are subject to forfeiture in the event the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option as described in the issuer's Registration Statement.

F3: These shares are held of record by the Sponsor. The Sponsor is beneficially owned and controlled by the Reporting Person, Lisa Gray, and Zoltan Kerekes, each of whom may be deemed to have beneficial ownership over these shares. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

Filing footnotes · ownership attribution and instrument terms

F1: As described in the issuer's registration statement on Form S-1 (File No. 333-252863) (the "Registration Statement") under the heading "Description of Securities--Founder Shares," the shares of Class B ordinary shares, par value $0.0001 per share, will automatically be converted into shares of Class A ordinary shares, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis subject to adjustment pursuant to certain anti-dilution rights described therein.

F2: These shares represent Class B ordinary shares held by PIPV Capital LLC (the "Sponsor") acquired pursuant to a subscription agreement by and between the Sponsor and the issuer and a subsequent share dividend of Class B ordinary shares to the Sponsor. The Class B ordinary shares owned by the Sponsor includes up to 450,000 shares that are subject to forfeiture in the event the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option as described in the issuer's Registration Statement.

F3: These shares are held of record by the Sponsor. The Sponsor is beneficially owned and controlled by the Reporting Person, Lisa Gray, and Zoltan Kerekes, each of whom may be deemed to have beneficial ownership over these shares. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

KKR FS Income Trust

Report date May 29, 2023 · Filed May 30, 2023

This filing explicitly reported no securities owned.

KKR FS Income Trust Select

Report date June 07, 2023 · Filed June 07, 2023

This filing explicitly reported no securities owned.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 25, 2024 Filed Nov 26, 2024 19:38 UTC FS KKR Capital Corp FSK · Entity 776 SaleCommon Stock 40,885 $22.01 $900,034.21
Disclosure

SEC source: 0001104659-24-123024 · tm2429617-1_4seq1.xml · nonDerivative · entry 1

IMASOGIE OSAGIE O · CIK 0001275878 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,603

F1 · price: The sales were effectuated in multiple transactions at prices ranging from $21.97 to $22.04. The price reported in Column 4 is the weighted average price

Read SEC document
August 11, 2021 Filed Aug 12, 2021 21:01 UTC FS KKR Capital Corp FSK · Entity 776 PurchaseCommon Stock 39,825 $22.74 $905,457.22
Disclosure

SEC source: 0001387131-21-008417 · imasogie-form4_081121.xml · nonDerivative · entry 1

IMASOGIE OSAGIE O · CIK 0001275878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,488

F1 · balance_after: Effective on June 15, 2020, FS KKR Capital Corp. ("FSK") effected a 4 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Read SEC document
March 04, 2020 Filed Mar 5, 2020 21:49 UTC FS KKR Capital Corp FSK · Entity 776 PurchaseCommon Stock 18,083 $5.59 $101,071.31
Disclosure

SEC source: 0001387131-20-002602 · ownership.xml · nonDerivative · entry 1

IMASOGIE OSAGIE O · CIK 0001275878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,658

F1 · kind: The purchases were effected in multiple transactions at prices ranging from $5.585 to $5.60, inclusive. The price reported in Column 4 is the weighted average price. The reporting person undertakes to provide, upon request, full information regarding the number of shares purchased in each transaction.

Read SEC document
November 20, 2019 Filed Nov 20, 2019 22:18 UTC FS KKR Capital Corp FSK · Entity 776 PurchaseCommon Stock 16,575 $6.04 $100,113.00
Disclosure

SEC source: 0001387131-19-008923 · imasogie-form4_112019.xml · nonDerivative · entry 1

IMASOGIE OSAGIE O · CIK 0001275878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,575

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.